-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Initiates Coverage On Revolution Medicines with Market Perform Rating, Announces Price Target of $151

Benzinga·05/22/2026 13:48:42
Listen to the news
Bernstein analyst Jeffrey Walch initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Market Perform rating and announces Price Target of $151.